Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)

Historic Other Non-Current Liabilities for HeartSciences (HSCS) over the last 3 years, with Q4 2024 value amounting to $32103.0.

  • HeartSciences' Other Non-Current Liabilities changed N/A to $32103.0 in Q4 2024 from the same period last year, while for Oct 2024 it was $32103.0, marking a year-over-year change of. This contributed to the annual value of $187450.0 for FY2023, which is 1950.38% down from last year.
  • According to the latest figures from Q4 2024, HeartSciences' Other Non-Current Liabilities is $32103.0.
  • HeartSciences' 5-year Other Non-Current Liabilities high stood at $232868.0 for Q2 2022, and its period low was $32103.0 during Q4 2024.
  • Its 3-year average for Other Non-Current Liabilities is $166926.3, with a median of $195514.0 in 2023.
  • Over the last 5 years, HeartSciences' Other Non-Current Liabilities had its largest YoY gain of 5046.5% in 2023, and its largest YoY loss of 1950.38% in 2023.
  • Quarter analysis of 3 years shows HeartSciences' Other Non-Current Liabilities stood at $137967.0 in 2022, then surged by 50.46% to $207592.0 in 2023, then tumbled by 84.54% to $32103.0 in 2024.
  • Its last three reported values are $32103.0 in Q4 2024, $207592.0 for Q3 2023, and $187450.0 during Q2 2023.